|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000165071 |
Summary for TMEM71 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000165071 | Gene symbol | TMEM71 |
| Gene name | transmembrane protein 71 | |
| HGNC | 26572 | |
| Entrez ID | 137835 | |
| Gene type | protein_coding | |
| Synonyms | TMEM71|FLJ33069 | |
| UniProtAcc | Q6P5X7 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for TMEM71 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| TMEM71 | 1.71e+02 | 1.58e+00 | 2.45e-01 | 6.43e+00 | 1.24e-10 | 7.96e-10 | KIRP |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| TMEM71 | 2.05e+02 | -1.33e+00 | 1.50e-01 | -8.89e+00 | 6.12e-19 | 1.98e-18 | BRCA |
Top |
Sex-biased somatic mutation for TMEM71 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for TMEM71 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg03141298 | chr8:132760411 | CGI:chr8:132775195-132775790 | promoter,gene body | 3.18e-01 | 4.73e-01 | -2.50e+00 | 1.26e-02 | 2.91e-02 | -1.55e-01 |
| BRCA | cg27159719 | chr8:132760496 | CGI:chr8:132775195-132775790 | UTR,promoter,exon,gene body | 4.99e-01 | 6.93e-01 | -2.70e+00 | 6.96e-03 | 2.32e-02 | -1.94e-01 |
| BRCA | cg20955688 | chr8:132760643 | CGI:chr8:132775195-132775790 | promoter,exon,gene body | 4.43e-01 | 6.47e-01 | -2.89e+00 | 3.90e-03 | 1.84e-02 | -2.04e-01 |
| LIHC | cg23313885 | chr8:132760869 | CGI:chr8:132775195-132775790 | promoter | 3.26e-01 | 2.16e-01 | 3.55e+00 | 3.85e-04 | 1.90e-03 | 1.10e-01 |
| SARC | cg23313885 | chr8:132760869 | CGI:chr8:132775195-132775790 | promoter | 4.60e-01 | 2.97e-01 | 2.85e+00 | 4.32e-03 | 1.04e-02 | 1.63e-01 |
| SARC | cg20955688 | chr8:132760643 | CGI:chr8:132775195-132775790 | promoter,exon,gene body | 3.14e-01 | 1.94e-01 | 3.50e+00 | 4.71e-04 | 1.91e-03 | 1.19e-01 |
| SARC | cg10054641 | chr8:132760847 | CGI:chr8:132775195-132775790 | promoter | 5.19e-01 | 3.84e-01 | 3.45e+00 | 5.68e-04 | 2.23e-03 | 1.36e-01 |
| SARC | cg05598678 | chr8:132760853 | CGI:chr8:132775195-132775790 | promoter | 3.90e-01 | 2.45e-01 | 3.95e+00 | 7.88e-05 | 4.15e-04 | 1.45e-01 |
| KICH | cg20955688 | chr8:132760643 | CGI:chr8:132775195-132775790 | promoter,exon,gene body | 6.10e-01 | 4.91e-01 | 2.26e+00 | 2.36e-02 | 3.96e-02 | 1.19e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg27159719 | chr8:132760496 | CGI:chr8:132775195-132775790 | UTR,promoter,exon,gene body | 4.75e-01 | 5.84e-01 | -3.48e+00 | 5.10e-04 | 8.56e-04 | -1.08e-01 |
| HNSC | cg23313885 | chr8:132760869 | CGI:chr8:132775195-132775790 | promoter | 4.03e-01 | 5.89e-01 | -2.91e+00 | 3.62e-03 | 5.40e-03 | -1.86e-01 |
| HNSC | cg03141298 | chr8:132760411 | CGI:chr8:132775195-132775790 | promoter,gene body | 7.84e-02 | 2.10e-01 | -5.10e+00 | 3.42e-07 | 2.47e-06 | -1.31e-01 |
| HNSC | cg27159719 | chr8:132760496 | CGI:chr8:132775195-132775790 | UTR,promoter,exon,gene body | 2.02e-01 | 3.97e-01 | -4.40e+00 | 1.10e-05 | 4.10e-05 | -1.95e-01 |
| HNSC | cg20955688 | chr8:132760643 | CGI:chr8:132775195-132775790 | promoter,exon,gene body | 1.38e-01 | 2.72e-01 | -3.84e+00 | 1.22e-04 | 3.06e-04 | -1.33e-01 |
| HNSC | cg10054641 | chr8:132760847 | CGI:chr8:132775195-132775790 | promoter | 4.36e-01 | 6.20e-01 | -3.74e+00 | 1.82e-04 | 4.29e-04 | -1.84e-01 |
| HNSC | cg05598678 | chr8:132760853 | CGI:chr8:132775195-132775790 | promoter | 3.11e-01 | 5.09e-01 | -3.93e+00 | 8.56e-05 | 2.27e-04 | -1.98e-01 |
| LUSC | cg23313885 | chr8:132760869 | CGI:chr8:132775195-132775790 | promoter | 4.02e-01 | 6.43e-01 | -2.17e+00 | 3.03e-02 | 3.32e-02 | -2.40e-01 |
| LUSC | cg03141298 | chr8:132760411 | CGI:chr8:132775195-132775790 | promoter,gene body | 8.62e-02 | 2.13e-01 | -4.09e+00 | 4.34e-05 | 5.42e-04 | -1.27e-01 |
| LUSC | cg27159719 | chr8:132760496 | CGI:chr8:132775195-132775790 | UTR,promoter,exon,gene body | 2.27e-01 | 3.99e-01 | -3.74e+00 | 1.88e-04 | 9.38e-04 | -1.72e-01 |
| LUSC | cg20955688 | chr8:132760643 | CGI:chr8:132775195-132775790 | promoter,exon,gene body | 1.66e-01 | 2.86e-01 | -3.30e+00 | 9.77e-04 | 2.56e-03 | -1.20e-01 |
| LUSC | cg10054641 | chr8:132760847 | CGI:chr8:132775195-132775790 | promoter | 4.85e-01 | 6.57e-01 | -2.95e+00 | 3.14e-03 | 5.79e-03 | -1.72e-01 |
| LUSC | cg05598678 | chr8:132760853 | CGI:chr8:132775195-132775790 | promoter | 3.39e-01 | 5.04e-01 | -2.96e+00 | 3.10e-03 | 5.73e-03 | -1.65e-01 |
| LUSC | cg09502207 | chr8:132761976 | CGI:chr8:132775195-132775790 | promoter | 7.04e-01 | 8.71e-01 | -2.91e+00 | 3.66e-03 | 6.47e-03 | -1.67e-01 |
| COAD | cg09502207 | chr8:132761976 | CGI:chr8:132775195-132775790 | promoter | 6.60e-01 | 7.85e-01 | -2.00e+00 | 4.59e-02 | 4.68e-02 | -1.25e-01 |
| BLCA | cg23313885 | chr8:132760869 | CGI:chr8:132775195-132775790 | promoter | 3.83e-01 | 7.23e-01 | -3.31e+00 | 9.33e-04 | 2.15e-03 | -3.41e-01 |
| BLCA | cg03141298 | chr8:132760411 | CGI:chr8:132775195-132775790 | promoter,gene body | 1.32e-01 | 2.48e-01 | -3.88e+00 | 1.04e-04 | 4.13e-04 | -1.15e-01 |
| BLCA | cg27159719 | chr8:132760496 | CGI:chr8:132775195-132775790 | UTR,promoter,exon,gene body | 3.08e-01 | 5.24e-01 | -3.66e+00 | 2.56e-04 | 7.95e-04 | -2.16e-01 |
| BLCA | cg05598678 | chr8:132760853 | CGI:chr8:132775195-132775790 | promoter | 3.25e-01 | 4.77e-01 | -3.04e+00 | 2.35e-03 | 4.46e-03 | -1.53e-01 |
| KIRP | cg23313885 | chr8:132760869 | CGI:chr8:132775195-132775790 | promoter | 3.57e-01 | 6.94e-01 | -3.12e+00 | 1.84e-03 | 3.05e-03 | -3.37e-01 |
| KIRP | cg20955688 | chr8:132760643 | CGI:chr8:132775195-132775790 | promoter,exon,gene body | 1.89e-01 | 4.56e-01 | -4.25e+00 | 2.09e-05 | 6.93e-05 | -2.66e-01 |
| KIRP | cg05598678 | chr8:132760853 | CGI:chr8:132775195-132775790 | promoter | 2.60e-01 | 5.05e-01 | -3.96e+00 | 7.65e-05 | 2.07e-04 | -2.45e-01 |
| ESCA | cg03141298 | chr8:132760411 | CGI:chr8:132775195-132775790 | promoter,gene body | 1.42e-01 | 2.43e-01 | -2.05e+00 | 4.09e-02 | 4.70e-02 | -1.01e-01 |
| ESCA | cg27159719 | chr8:132760496 | CGI:chr8:132775195-132775790 | UTR,promoter,exon,gene body | 3.18e-01 | 5.40e-01 | -2.74e+00 | 6.15e-03 | 3.49e-02 | -2.22e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg03141298 | chr8:132760411 | CGI:chr8:132775195-132775790 | promoter,gene body | 3.18e-01 | 1.84e-01 | 5.76e+00 | 8.41e-09 | 1.89e-08 | 1.34e-01 |
| BRCA | cg20955688 | chr8:132760643 | CGI:chr8:132775195-132775790 | promoter,exon,gene body | 4.43e-01 | 2.60e-01 | 7.89e+00 | 3.07e-15 | 1.14e-14 | 1.84e-01 |
| BRCA | cg05598678 | chr8:132760853 | CGI:chr8:132775195-132775790 | promoter | 5.53e-01 | 4.28e-01 | 5.75e+00 | 8.78e-09 | 1.97e-08 | 1.25e-01 |
| BRCA | cg09502207 | chr8:132761976 | CGI:chr8:132775195-132775790 | promoter | 6.85e-01 | 8.54e-01 | -8.24e+00 | 1.67e-16 | 6.84e-16 | -1.69e-01 |
| KIRC | cg09502207 | chr8:132761976 | CGI:chr8:132775195-132775790 | promoter | 7.78e-01 | 9.03e-01 | -2.54e+00 | 1.12e-02 | 1.84e-02 | -1.26e-01 |
Top |
Exon skipping events with PSI in TCGA for TMEM71 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for TMEM71 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for TMEM71 |
| TFs related to TMEM71. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CHOL | FOXD2 | TMEM71 | 4.70e+00 | 9.80e-01 | 3.84e+00 | 1.58e-02 | Male-biased |
| CHOL | SIX1 | TMEM71 | 4.95e+00 | 9.87e-01 | 3.97e+00 | 9.85e-03 | Male-biased |
| CHOL | SOX2 | TMEM71 | 4.74e+00 | 9.87e-01 | 3.75e+00 | 9.38e-03 | Male-biased |
| CHOL | SRY | TMEM71 | 5.14e+00 | 9.84e-01 | 4.23e+00 | 1.34e-02 | Male-biased |
| CHOL | ZNF33B | TMEM71 | 4.81e+00 | 9.90e-01 | 3.72e+00 | 6.36e-03 | Male-biased |
| CHOL | ZNF580 | TMEM71 | 4.97e+00 | 9.82e-01 | 4.11e+00 | 1.57e-02 | Male-biased |
| DLBC | ESR2 | TMEM71 | 3.64e+00 | 1.10e-02 | 4.51e+00 | 9.82e-01 | Female-biased |
| DLBC | FOXD2 | TMEM71 | 4.35e+00 | 9.80e-01 | 3.50e+00 | 1.05e-02 | Male-biased |
| DLBC | KLF8 | TMEM71 | 3.79e+00 | 1.23e-02 | 4.63e+00 | 9.82e-01 | Female-biased |
| DLBC | REST | TMEM71 | 3.59e+00 | 9.40e-03 | 4.50e+00 | 9.84e-01 | Female-biased |
| DLBC | TFAP4 | TMEM71 | 3.53e+00 | 1.18e-02 | 4.38e+00 | 9.80e-01 | Female-biased |
| DLBC | ZNF101 | TMEM71 | 3.44e+00 | 5.26e-03 | 4.51e+00 | 9.88e-01 | Female-biased |
| DLBC | ZNF331 | TMEM71 | 3.33e+00 | 3.57e-03 | 4.51e+00 | 9.90e-01 | Female-biased |
| LAML | ZNF334 | TMEM71 | 3.77e+00 | 1.20e-02 | 4.62e+00 | 9.81e-01 | Female-biased |
| LGG | ESR2 | TMEM71 | 4.41e+00 | 9.82e-01 | 3.91e+00 | 8.53e-03 | Male-biased |
| LGG | GTF3A | TMEM71 | 4.54e+00 | 9.86e-01 | 4.00e+00 | 6.82e-03 | Male-biased |
| LGG | KLF8 | TMEM71 | 4.53e+00 | 9.88e-01 | 3.91e+00 | 4.29e-03 | Male-biased |
| LGG | MAX | TMEM71 | 5.07e+00 | 9.82e-01 | 4.67e+00 | 1.50e-02 | Male-biased |
| LGG | REST | TMEM71 | 4.34e+00 | 9.85e-01 | 3.74e+00 | 4.62e-03 | Male-biased |
| LGG | TFAP4 | TMEM71 | 4.38e+00 | 9.83e-01 | 3.87e+00 | 7.68e-03 | Male-biased |
| LGG | ZNF101 | TMEM71 | 4.25e+00 | 9.84e-01 | 3.65e+00 | 4.59e-03 | Male-biased |
| LGG | ZNF331 | TMEM71 | 4.54e+00 | 9.89e-01 | 3.91e+00 | 4.08e-03 | Male-biased |
| LGG | ZNF423 | TMEM71 | 5.27e+00 | 9.82e-01 | 4.87e+00 | 1.57e-02 | Male-biased |
| LGG | ZNF483 | TMEM71 | 4.16e+00 | 9.81e-01 | 3.58e+00 | 5.33e-03 | Male-biased |
| LGG | ZSCAN5 | TMEM71 | 4.60e+00 | 9.82e-01 | 4.15e+00 | 1.14e-02 | Male-biased |
| MESO | BARHL2 | TMEM71 | 5.68e+00 | 9.89e-01 | 4.44e+00 | 9.32e-03 | Male-biased |
| MESO | FOXD2 | TMEM71 | 5.07e+00 | 9.95e-01 | 3.43e+00 | 2.43e-03 | Male-biased |
| MESO | FOXF1 | TMEM71 | 4.89e+00 | 9.94e-01 | 3.25e+00 | 2.33e-03 | Male-biased |
| MESO | FOXQ1 | TMEM71 | 4.83e+00 | 9.93e-01 | 3.24e+00 | 2.91e-03 | Male-biased |
| MESO | FOXR2 | TMEM71 | 4.52e+00 | 9.93e-01 | 2.51e+00 | 5.86e-04 | Male-biased |
| MESO | MYNN | TMEM71 | 4.63e+00 | 9.91e-01 | 3.14e+00 | 3.93e-03 | Male-biased |
| MESO | PDX1 | TMEM71 | 5.38e+00 | 9.93e-01 | 3.93e+00 | 4.75e-03 | Male-biased |
| MESO | POU6F2 | TMEM71 | 5.56e+00 | 9.95e-01 | 3.98e+00 | 3.09e-03 | Male-biased |
| MESO | PRDM1 | TMEM71 | 4.52e+00 | 9.90e-01 | 3.03e+00 | 3.99e-03 | Male-biased |
| MESO | SIX1 | TMEM71 | 4.78e+00 | 9.87e-01 | 3.52e+00 | 8.55e-03 | Male-biased |
| MESO | SOX2 | TMEM71 | 4.82e+00 | 9.92e-01 | 3.33e+00 | 3.94e-03 | Male-biased |
| MESO | SRY | TMEM71 | 5.32e+00 | 9.94e-01 | 3.84e+00 | 4.27e-03 | Male-biased |
| MESO | VENTX | TMEM71 | 6.56e+00 | 9.86e-01 | 5.44e+00 | 1.39e-02 | Male-biased |
| MESO | ZNF101 | TMEM71 | 2.11e+00 | 1.27e-03 | 3.95e+00 | 9.83e-01 | Female-biased |
| MESO | ZNF3 | TMEM71 | 4.45e+00 | 9.83e-01 | 3.23e+00 | 9.52e-03 | Male-biased |
| MESO | ZNF331 | TMEM71 | 2.26e+00 | 2.10e-03 | 3.97e+00 | 9.83e-01 | Female-biased |
| MESO | ZNF334 | TMEM71 | 4.51e+00 | 9.93e-01 | 2.31e+00 | 2.95e-04 | Male-biased |
| MESO | ZNF33B | TMEM71 | 4.80e+00 | 9.94e-01 | 3.05e+00 | 1.61e-03 | Male-biased |
| MESO | ZNF418 | TMEM71 | 4.31e+00 | 9.91e-01 | 2.07e+00 | 2.61e-04 | Male-biased |
| MESO | ZNF580 | TMEM71 | 5.20e+00 | 9.95e-01 | 3.60e+00 | 2.79e-03 | Male-biased |
| MESO | ZNF780A | TMEM71 | 1.53e+00 | 2.23e-04 | 3.80e+00 | 9.81e-01 | Female-biased |
| MESO | ZNF79 | TMEM71 | 4.40e+00 | 9.92e-01 | 2.37e+00 | 5.62e-04 | Male-biased |
| MESO | ZSCAN9 | TMEM71 | 4.94e+00 | 9.88e-01 | 3.69e+00 | 8.82e-03 | Male-biased |
| MESO | ZZZ3 | TMEM71 | 5.37e+00 | 9.81e-01 | 4.32e+00 | 1.70e-02 | Male-biased |
| PAAD | BPTF | TMEM71 | 4.56e+00 | 9.81e-01 | 3.78e+00 | 1.28e-02 | Male-biased |
| SARC | FOXD2 | TMEM71 | 4.98e+00 | 9.87e-01 | 4.42e+00 | 9.83e-03 | Male-biased |
| SARC | FOXQ1 | TMEM71 | 4.81e+00 | 9.90e-01 | 4.15e+00 | 5.63e-03 | Male-biased |
| SARC | FOXR2 | TMEM71 | 4.52e+00 | 9.92e-01 | 3.54e+00 | 9.22e-04 | Male-biased |
| SARC | MYNN | TMEM71 | 4.63e+00 | 9.87e-01 | 4.01e+00 | 7.08e-03 | Male-biased |
| SARC | POU6F2 | TMEM71 | 5.41e+00 | 9.88e-01 | 4.86e+00 | 1.05e-02 | Male-biased |
| SARC | SOX2 | TMEM71 | 4.83e+00 | 9.82e-01 | 4.32e+00 | 1.33e-02 | Male-biased |
| SARC | SRY | TMEM71 | 5.28e+00 | 9.87e-01 | 4.73e+00 | 1.10e-02 | Male-biased |
| SARC | ZNF334 | TMEM71 | 4.55e+00 | 9.93e-01 | 3.42e+00 | 3.98e-04 | Male-biased |
| SARC | ZNF33B | TMEM71 | 4.75e+00 | 9.80e-01 | 4.25e+00 | 1.50e-02 | Male-biased |
| SARC | ZNF418 | TMEM71 | 4.35e+00 | 9.91e-01 | 2.73e+00 | 2.61e-05 | Male-biased |
| SARC | ZNF580 | TMEM71 | 5.15e+00 | 9.92e-01 | 4.48e+00 | 5.22e-03 | Male-biased |
| SARC | ZNF79 | TMEM71 | 4.43e+00 | 9.92e-01 | 3.26e+00 | 3.30e-04 | Male-biased |
| SARC | ZNF879 | TMEM71 | 3.88e+00 | 9.80e-01 | 2.44e+00 | 6.91e-05 | Male-biased |
| SKCM | ZNF418 | TMEM71 | 4.80e+00 | 1.04e-02 | 5.77e+00 | 9.88e-01 | Female-biased |
| TMEM71 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for TMEM71 |
| RBPs related to ES in TMEM71. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| TMEM71 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs79082040 | chr8:124745564:A:C | - | 0.0438601149144251 | 0.0372895891772758 | LUAD | Female-baised eQTL |
| rs146122966 | chr8:124745846:T:C | - | 0.0428063046392722 | 0.0455887123190562 | LUAD | Female-baised eQTL |
| rs62528822 | chr8:124746789:G:A | - | 0.0428063046392722 | 0.0455887123190562 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4621788 | chr8:132557150:G:T | - | 0.128582306512949 | 0.0285676351298909 | GBM | Male-baised eQTL |
| rs78208280 | chr8:130819465:C:T | - | 0.166380484398136 | 0.0014491865389431 | SARC | Male-baised eQTL |
| rs142534387 | chr8:132082879:A:G | - | -0.162717706743635 | 0.00501226892170479 | SARC | Male-baised eQTL |
| rs4736539 | chr8:132084969:T:C | - | -0.162717706743635 | 0.00501226892170479 | SARC | Male-baised eQTL |
| rs12677995 | chr8:132088377:A:G | - | -0.162717706743635 | 0.00501226892170479 | SARC | Male-baised eQTL |
| rs4736401 | chr8:132089762:T:C | - | -0.162262540074477 | 0.00541071363714802 | SARC | Male-baised eQTL |
| rs4736543 | chr8:132088176:T:C | - | -0.151571671312644 | 0.00847359936075229 | SARC | Male-baised eQTL |
| rs4736400 | chr8:132086202:A:T | - | -0.151544399827696 | 0.0121379272875755 | SARC | Male-baised eQTL |
| rs7003013 | chr8:132087427:A:C | - | -0.151544399827696 | 0.0121379272875755 | SARC | Male-baised eQTL |
| rs6471038 | chr8:132089571:G:A | - | -0.151113077683983 | 0.0128765240864302 | SARC | Male-baised eQTL |
| rs891764 | chr8:132090404:A:G | - | -0.151113077683983 | 0.0128765240864302 | SARC | Male-baised eQTL |
| rs6989522 | chr8:139204933:A:G | - | 0.113222538625343 | 0.0154866216735672 | SARC | Male-baised eQTL |
| rs7824804 | chr8:132094292:T:C | - | -0.137044692389719 | 0.0246242192246929 | SARC | Male-baised eQTL |
| rs7828744 | chr8:132094651:T:C | - | -0.137044692389719 | 0.0246242192246929 | SARC | Male-baised eQTL |
| rs28662400 | chr8:126627959:A:C | - | 0.164383674461348 | 0.0267617585447 | SARC | Male-baised eQTL |
| rs10101684 | chr8:130681071:C:G | - | 0.0964977657717346 | 0.0386365111264302 | SARC | Male-baised eQTL |
| rs11780296 | chr8:132093868:A:T | - | -0.128277707254466 | 0.0473901613564984 | SARC | Male-baised eQTL |
| rs181118525 | chr8:134755179:G:A | - | 0.0931232242823015 | 0.0199392399512769 | LUAD | Male-baised eQTL |
| rs117867340 | chr8:134752787:G:C | - | 0.0822400320361365 | 0.043188930483499 | LUAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000165071 |
| CpG Site: cg05598678 | |
| Position to Gene: promoter | |
| Male Effect: - | |
| Female Effect: -0.0574049506674557 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg05598678 | chr8:132760853 | promoter | -0.0574049506674557 | 2.13022331967347e-05 | -0.3327251446656802 | 5.2402685822085966e-08 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of TMEM71 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
